0
0
0
Raising awareness for the sarcoma cancer chordoma.
2/5/2024, 2:30 PM
Summary of Bill HRES 937
Bill 118 H.Res. 937, also known as the "Raising Awareness for Sarcoma Cancer Chordoma" bill, is a piece of legislation introduced in the US Congress with the aim of increasing awareness and understanding of the rare cancer known as chordoma. Chordoma is a type of sarcoma cancer that affects the bones of the skull and spine, and is often difficult to diagnose and treat.
The bill highlights the need for increased research funding, improved access to treatment options, and better support for patients and their families affected by chordoma. It also calls for greater collaboration among healthcare providers, researchers, and patient advocacy groups to advance knowledge and treatment of this rare cancer.
If passed, this bill would help raise awareness about chordoma and the challenges faced by those living with this disease. It would also encourage efforts to improve early detection, diagnosis, and treatment options for patients, ultimately leading to better outcomes and quality of life for those affected by chordoma. Overall, Bill 118 H.Res. 937 seeks to bring attention to the unique needs of individuals with chordoma and to promote efforts to advance research and support for this rare form of cancer.
The bill highlights the need for increased research funding, improved access to treatment options, and better support for patients and their families affected by chordoma. It also calls for greater collaboration among healthcare providers, researchers, and patient advocacy groups to advance knowledge and treatment of this rare cancer.
If passed, this bill would help raise awareness about chordoma and the challenges faced by those living with this disease. It would also encourage efforts to improve early detection, diagnosis, and treatment options for patients, ultimately leading to better outcomes and quality of life for those affected by chordoma. Overall, Bill 118 H.Res. 937 seeks to bring attention to the unique needs of individuals with chordoma and to promote efforts to advance research and support for this rare form of cancer.
Congressional Summary of HRES 937
This resolution expresses the sense of the House of Representatives of the need for increased funding and support for diagnosis, treatments, and cures for chordoma (a bone cancer of the skull and spine).
Read the Full Bill
Current Status of Bill HRES 937
Bill HRES 937 is currently in the status of Bill Introduced since December 14, 2023. Bill HRES 937 was introduced during Congress 118 and was introduced to the House on December 14, 2023. Bill HRES 937's most recent activity was Referred to the Subcommittee on Health. as of December 15, 2023
Bipartisan Support of Bill HRES 937
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
12Democrat Cosponsors
8Republican Cosponsors
4Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HRES 937
Primary Policy Focus
HealthAlternate Title(s) of Bill HRES 937
Raising awareness for the sarcoma cancer chordoma.
Raising awareness for the sarcoma cancer chordoma.
Comments
Sponsors and Cosponsors of HRES 937
Latest Bills
RISE Act
Bill S 3589August 14, 2026
Federal Building Threat Notification Act
Bill S 2542August 14, 2026
A bill to require the United States Postal Service to designate ZIP Codes for certain communities.
Bill S 4505August 14, 2026
A bill to expand the sharing of information with respect to suspected violations of intellectual property rights in trade.
Bill S 2677August 14, 2026
USMMA Athletics Act of 2026
Bill S 3266August 13, 2026
Space Commerce Advisory Committee Act
Bill S 434August 13, 2026
Diversity Jurisdiction Inflation Adjustment Act
Bill S 4850August 13, 2026
Officer John Barnes and Chief Michael Ansbro Public Safety Officers' Benefit Program Expansion Act of 2026
Bill S 3897August 13, 2026
National Defense Authorization Act for Fiscal Year 2027
Bill S 4784August 13, 2026
Cahokia Mounds Mississippian Culture Study Act
Bill S 1516August 13, 2026





